| related words |
| acapodene |
| diamondback |
| tmr |
| mammography |
| igfd |
| biodefense |
| isatoribine |
| ampyra |
| orion |
| kidney |
| dosage |
| hyaluronan |
| staccato |
| eligard |
| prohibitive |
| keflex |
| disorder |
| isolagen |
| pdx |
| emerges |
|
| related documents |
| 946840--3/2/2009--VIROPHARMA_INC |
|
| related topics |
| {product, liability, claim} |
| {product, candidate, development} |
| {product, market, service} |
| {capital, credit, financial} |
| {loan, real, estate} |
| {stock, price, operating} |
| {debt, indebtedness, cash} |
| {tax, income, asset} |
| {competitive, industry, competition} |
| {investment, property, distribution} |
| {operation, natural, condition} |
| {acquisition, growth, future} |
| {control, financial, internal} |
| {gas, price, oil} |
| {cost, regulation, environmental} |
| {interest, director, officer} |
| {regulation, government, change} |
| {cost, contract, operation} |
| {condition, economic, financial} |
| {customer, product, revenue} |
|